RxDoctor Payments DataLook up a doctor →

Jason Meyers, MD

Clinical Cardiac Electrophysiology · West Des Moines, IANPI 1750518478

Payments from drug & device makers

$450,620in general payments, 2019–2025

Across 1,030 payments — averaging $437.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$259K
  • Medtronic$79K
  • Abbott$54K
  • Impulse Dynamics (USA) Inc.$46K
  • Philips North America LLC$6K
  • Atricure, Inc.$3K
  • plus $3K from 20 others
$800in research payments, 2019–2025

Across 1 payment — averaging $800.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$800

What the payments were for

  • Consulting fees$54,95029%
  • Speaking & faculty fees$72,81339%
  • Travel & lodging$33,03918%
  • Food & beverage$27,68215%
  • Education$1420%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$450,620 in reported general payments places this provider in the 95th percentile of 42 clinical cardiac electrophysiology providers in Iowa.

See all clinical cardiac electrophysiology providers in Iowa

Medicare billing

Part B allowed, 2024
$223,163
Medicare patients
1,908
Services billed
4,799

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban278$191,864
XareltoRivaroxaban47$30,895
Flecainide Acetate80$1,817
Amiodarone Hcl207$1,645
Dofetilide15$1,627
Metoprolol Succinate185$1,074
SotalolSotalol Hcl59$728
Propafenone Hcl19$631
Dilt-XrDiltiazem Hcl17$403
Diltiazem 24hr Er (Cd)Diltiazem Hcl35$302
Warfarin Sodium23$272
Midodrine Hcl12$225
Pantoprazole Sodium48$181
Bisoprolol Fumarate15$144
Diltiazem 24hr ErDiltiazem Hcl12$126

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$14$191,864278 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 42 clinical cardiac electrophysiology providers in Iowa.

Other clinical cardiac electrophysiology in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →